UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 19, 2020
Accession Number:
Submission Type:
CIK: 0001600620
Company Name: Aurinia Pharmaceuticals Inc.
File Number: 333-238785